Page last updated: 2024-12-06

n-methylacetamide-oxotremorine m

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methylacetamide-oxotremorine M: RN given refers to iodide; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID19719
MeSH IDM0126071

Synonyms (12)

Synonym
trimethyl(4-(n-methyl-acetamido)but-2-ynyl)ammonium iodide
ammonium, (4-(n-methylacetamido)-2-butynyl)trimethyl-, iodide
n-methylacetamide-oxotremorine m
2-butyn-1-aminium, 4-(acetylmethylamino)-n,n,n-trimethyl-, iodide
uh 28 methiodide
n-methylacetamide-oxotremorine m iodide
oxotremorine m-n-methylacetamide
3854-07-7
4-[acetyl(methyl)amino]but-2-ynyl-trimethylazanium;iodide
DTXSID00959408
4-[acetyl(methyl)amino]-n,n,n-trimethylbut-2-yn-1-aminium iodide
n,n,n-trimethyl-4-(n-methylacetamido)but-2-yn-1-aminium iodide

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response curves obtained in the presence of oxotremorine-M for inositol lipid turnover in both the nerve-ending fraction and slice preparation correlated with the occupancy of a single low-affinity form of the muscarinic receptor."( Differential stimulation of inositol phospholipid turnover in brain by analogs of oxotremorine.
Bartus, RT; Figueiredo, JC; Fisher, SK, 1984
)
0.27
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-199031 (72.09)18.7374
1990's0 (0.00)18.2507
2000's1 (2.33)29.6817
2010's2 (4.65)24.3611
2020's9 (20.93)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.66 (24.57)
Research Supply Index3.81 (2.92)
Research Growth Index5.47 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]